W-S Xu

Molecular Biology · 2009

A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom W-S Xu trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Weisheng Xu
  2. PA Marks

Papers from W-S Xu's perspective

Ordered by how strongly the researchers W-S Xu trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Anticancer activities of histone deacetylase inhibitors (Nature reviews. Drug discovery)
  2. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation (Proceedings of the National Academy of Sciences of the United States of America)
  3. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug (Nature Biotechnology)
  4. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. (Structure)
  5. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. (Proceedings of the National Academy of Sciences of the United States of America)
  6. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. (Proceedings of the National Academy of Sciences of the United States of America)
  7. Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. (Proceedings of the National Academy of Sciences of the United States of America)
  8. Histone Deacetylase Inhibitors for Cancer Therapy (Epigenetics)
  9. Histone deacetylase inhibitors: molecular mechanisms of action (Oncogene)
  10. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses (Science)

Their papers